SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...

Several dozen people gathered at Clovis Community Medical Center to celebrate patients living with a Left Ventricular Assist ...

This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA. DENVER, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation ( ...

DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical ...

ABT has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options. The TEAM-HF trial is ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit ...

“I could say for every one of the staff that works here, they go over and beyond the call of duty to make sure I’m satisfied,” said LVAD patient Larry Pippen Sr. And the team feels likewise.